Old Web
English
Sign In
Acemap
>
Paper
>
1213 A HIGHLY POTENT HCV NS5A INHIBITOR EDP-239 WITH FAVORABLE PRECLINICAL PHARMACOKINETICS
1213 A HIGHLY POTENT HCV NS5A INHIBITOR EDP-239 WITH FAVORABLE PRECLINICAL PHARMACOKINETICS
2011
Lijuan Jiang
S. Liu
T. Phan
Christopher M. Owens
Bradley B. Brasher
A. Polemeropoulos
X. Luo
Khanh Hoang
M. Wang
Xiaowen Peng
Hui Cao
Yao-Ling Qiu
Yat Sun Or
Keywords:
HCV NS5A Inhibitor
Virology
Diabetes mellitus
Medicine
Pharmacokinetics
Pharmacology
preclinical pharmacokinetics
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]